Design Therapeutics, Inc.
Design Therapeutics develops GeneTAC small molecules that modulate expression of disease-causing genes.
424B4Sep 28Latest SEC filing
Aug 3Latest story
August 2026
Sign inSign inDesign Therapeutics develops GeneTAC small molecules that modulate expression of disease-causing genes.